Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
European Child & Adolescent Psychiatry
Published in: European Child & Adolescent Psychiatry 9/2017

01-09-2017 | Review

Vitamin D and mental health in children and adolescents

Authors: Manuel Föcker, Jochen Antel, Stefanie Ring, Denise Hahn, Özlem Kanal, Dana Öztürk, Johannes Hebebrand, Lars Libuda

Published in: European Child & Adolescent Psychiatry | Issue 9/2017

Login to get access

Abstract

While vitamin D is known to be relevant for bone health, evidence has recently accumulated for an impact on mental health. To identify the potential benefits and limitations of vitamin D for mental health, an understanding of the physiology of vitamin D, the cut-off values for vitamin D deficiency and the current status of therapeutic trials is paramount. Results of a systematic PUBMED search highlight the association of vitamin D levels and mental health conditions. Here, we focus on children and adolescents studies as well as randomized controlled trials on depression in adults. 41 child and adolescent studies were identified including only 1 randomized controlled and 7 non-controlled supplementation trials. Overall, results from 25 cross-sectional studies as well as from 8 longitudinal studies suggest a role of vitamin D in the pathogenesis of mental disorders in childhood and adolescence. Findings from supplementation trials seem to support this hypothesis. However, randomized controlled trials in adults revealed conflicting results. Randomized controlled trials in childhood and adolescents are urgently needed to support the potential of vitamin D as a complementary therapeutic option in mental disorders. Study designs should consider methodological challenges, e.g., hypovitaminosis D at baseline, appropriate supplementation doses, sufficient intervention periods, an adequate power, clinically validated diagnostic instruments, and homogenous, well-defined risk groups.
Literature
1.
Murray F (2009) Natural Supplements for diabetes: practical and proven health suggestions for types 1 and 2 diabetes: Easyread Large Bold Edition. CREATESPACE PUB
2.
Tripkovic L et al (2012) Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 95(6):1357–1364PubMedPubMedCentralCrossRef
3.
Trang HM et al (1998) Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 68(4):854–858PubMed
4.
5.
Brown AJ, Dusso A, Slatopolsky E (1999) Vitamin D. Am J Physiol 277(2 Pt 2):F157–F175PubMed
6.
Holick MF (1995) Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 61(3 Suppl):638S–645SPubMed
7.
8.
Lehmann U et al (2015) Efficacy of fish intake on vitamin D status: a meta-analysis of randomized controlled trials. Am J Clin Nutr 102(4):837–847PubMedCrossRef
9.
10.
Lu Z et al (2007) An evaluation of the vitamin D3 content in fish: is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? J Steroid Biochem Mol Biol 103(3–5):642–644PubMedPubMedCentralCrossRef
11.
12.
Vieth R (2004) Why “vitamin D” is not a hormone, and not a synonym for 1,25-dihydroxy-vitamin D, its analogs or deltanoids. J Steroid Biochem Mol Biol 89–90(1–5):571–573PubMedCrossRef
13.
Pike JW et al (2010) Emerging regulatory paradigms for control of gene expression by 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 121(1–2):130–135PubMedPubMedCentralCrossRef
14.
15.
Ryan JW, Anderson PH, Morris HA (2015) Pleiotropic activities of vitamin D receptors—adequate activation for multiple health outcomes. Clin Biochem Rev 36(2):53–61PubMedPubMedCentral
16.
Christakos S et al (2016) Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 96(1):365–408PubMedCrossRef
17.
Yoshizawa T et al (1997) Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16(4):391–396PubMedCrossRef
18.
19.
Cui X et al (2015) Vitamin D and the brain: key questions for future research. J Steroid Biochem Mol Biol 148:305–309PubMedCrossRef
20.
Annweiler C et al (2010) Dietary intake of vitamin D and cognition in older women: a large population-based study. Neurology 75(20):1810–1816PubMedCrossRef
21.
Brouwer-Brolsma EM et al (2013) Associations of 25-hydroxyvitamin D with fasting glucose, fasting insulin, dementia and depression in European elderly: the SENECA study. Eur J Nutr 52(3):917–925PubMedCrossRef
22.
23.
Ganji V et al (2010) Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. Int Arch Med 3:29PubMedPubMedCentralCrossRef
24.
Grant WB, Soles CM (2009) Epidemiologic evidence supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism. Dermatoendocrinology 1(4):223–228CrossRef
25.
Humble MB, Gustafsson S, Bejerot S (2010) Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis. J Steroid Biochem Mol Biol 121(1–2):467–470PubMedCrossRef
26.
Itzhaky D et al (2012) Low serum vitamin D concentrations in patients with schizophrenia. Isr Med Assoc J 14(2):88–92PubMed
27.
Kesby JP et al (2006) Developmental vitamin D deficiency alters MK 801-induced hyperlocomotion in the adult rat: an animal model of schizophrenia. Biol Psychiatry 60(6):591–596PubMedCrossRef
28.
Jaddou HY et al (2012) Depression is associated with low levels of 25-hydroxyvitamin D among Jordanian adults: results from a national population survey. Eur Arch Psychiatry Clin Neurosci 262(4):321–327PubMedCrossRef
29.
Milaneschi Y et al (2014) The association between low vitamin D and depressive disorders. Mol Psychiatry 19(4):444–451PubMedCrossRef
30.
Kamal M, Bener A, Ehlayel MS (2014) Is high prevalence of vitamin D deficiency a correlate for attention deficit hyperactivity disorder? Atten Defic Hyperact Disord 6(2):73–78PubMedCrossRef
31.
Eyles DW et al (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29(1):21–30PubMedCrossRef
32.
33.
Eyles DW, Burne TH, McGrath JJ (2013) Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 34(1):47–64PubMedCrossRef
34.
Staal WG (2016) Autism, vitamin D and early brain development. Hum Genet Embryol 6(2):1–3CrossRef
35.
36.
Neveu I et al (1994) 1,25-Dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport 6(1):124–126PubMedCrossRef
37.
Naveilhan P et al (1996) 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 7(13):2171–2175PubMedCrossRef
38.
Giese M et al (2014) Fast BDNF serum level increase and diurnal BDNF oscillations are associated with therapeutic response after partial sleep deprivation. J Psychiatr Res 59:1–7
39.
Mikoteit T et al (2014) High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression. Psychopharmacology 231(15):2955–2965PubMedCrossRef
40.
Pallavi P et al (2013) Serum neurotrophic factors in adolescent depression: gender difference and correlation with clinical severity. J Affect Disord 150(2):415–423PubMedCrossRef
41.
Pirotta S, Kidgell DJ, Daly RM (2015) Effects of vitamin D supplementation on neuroplasticity in older adults: a double-blinded, placebo-controlled randomised trial. Osteoporos Int 26(1):131–140PubMedCrossRef
42.
Cui X et al (2015) Vitamin D regulates tyrosine hydroxylase expression: n-cadherin a possible mediator. Neuroscience 304:90–100PubMedCrossRef
43.
Garcion E et al (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13(3):100–105PubMedCrossRef
44.
Kaneko I et al (2015) 1,25-Dihydroxyvitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: implication for behavioral influences of vitamin D. FASEB J 29(9):4023–4035PubMedCrossRef
45.
Huang YN et al (2015) 1,25-Dihydroxyvitamin D3 attenuates endotoxin-induced production of inflammatory mediators by inhibiting MAPK activation in primary cortical neuron-glia cultures. J Neuroinflamm 12:147CrossRef
46.
Braegger C et al (2013) Vitamin D in the healthy European paediatric population. J Pediatr Gastroenterol Nutr 56(6):692–701PubMedCrossRef
47.
Institute of Medicine (2011) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary reference intakes for calcium and vitamin D. National Academies Press
48.
Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930PubMedCrossRef
49.
Munns CF et al (2016) Global Consensus Recommendations on prevention and management of nutritional rickets. Horm Res Paediatr 85(2):83–106PubMedCrossRef
50.
Tolppanen AM et al (2012) Risk factors for variation in 25-hydroxyvitamin D(3) and D(2) concentrations and vitamin D deficiency in children. J Clin Endocrinol Metab 97(4):1202–1210PubMedCrossRef
51.
Lapatsanis D et al (2005) Vitamin D: a necessity for children and adolescents in Greece. Calcif Tissue Int 77(6):348–355PubMedCrossRef
52.
Andersen R et al (2008) Pakistani immigrant children and adults in Denmark have severely low vitamin D status. Eur J Clin Nutr 62(5):625–634PubMedCrossRef
53.
54.
55.
Gonzalez-Gross M et al (2012) Vitamin D status among adolescents in Europe: the Healthy Lifestyle in Europe by Nutrition in Adolescence study. Br J Nutr 107(5):755–764PubMedCrossRef
56.
57.
Wang T et al (2016) Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry 25(4):341–350PubMedCrossRef
58.
59.
60.
Meguid NA et al (2010) Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in Egyptian children with autism. J Altern Complement Med 16(6):641–645PubMedCrossRef
61.
62.
63.
Bener A, Kamal M (2014) Predict attention deficit hyperactivity disorder? Evidence-based medicine. Glob J Health Sci 6(2):47–57
64.
Bener A et al (2014) Higher prevalence of iron deficiency as strong predictor of attention deficit hyperactivity disorder in children. Ann Med Health Sci Res 4(Suppl 3):S291–S297PubMedPubMedCentralCrossRef
65.
Zhang M et al (2013) Do children with mental disorders have higher prevalence of hypovitaminosis D? F1000Research 2:159PubMedPubMedCentral
66.
Goksugur SB et al (2014) Vitamin D status in children with attention-deficit-hyperactivity disorder. Pediatr Int 56(4):515–519PubMedCrossRef
67.
68.
69.
Ataie-Jafari A et al (2015) The association of vitamin D deficiency with psychiatric distress and violence behaviors in Iranian adolescents: the CASPIAN-III study. J Diabetes Metab Disord 14:62PubMedPubMedCentralCrossRef
70.
71.
Sharif MR et al (2015) The relationship between serum vitamin D level and attention deficit hyperactivity disorder. Iran J Child Neurol 9(4):48–53PubMedPubMedCentral
72.
Meyer T et al (2016) Attention deficit-hyperactivity disorder is associated with reduced blood pressure and serum vitamin D levels: results from the nationwide German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Eur Child Adolesc Psychiatry. doi:10.​1007/​s00787-016-0852-3
73.
Neupane SP et al (2013) Vitamin D deficiency in alcohol-use disorders and its relationship to comorbid major depression: a cross-sectional study of inpatients in Nepal. Drug Alcohol Depend 133(2):480–485PubMedCrossRef
74.
75.
Adams JB et al (2011) Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond) 8(1):34PubMedCentralCrossRef
76.
Mostafa GA, Al-Ayadhi LY (2012) Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: relation to autoimmunity. J Neuroinflamm 9:201CrossRef
77.
Tostes MH et al (2012) Low serum levels of 25-hydroxyvitamin D (25-OHD) in children with autism. Trends Psychiatry Psychother 34(3):161–163PubMedCrossRef
78.
Bener A, Khattab AO, Al-Dabbagh MM (2014) Is high prevalence of vitamin D deficiency evidence for autism disorder?: in a highly endogamous population. J Pediatr Neurosci 9(3):227–233PubMedPubMedCentralCrossRef
79.
80.
Gong ZL et al (2014) Serum 25-hydroxyvitamin D levels in Chinese children with autism spectrum disorders. Neuroreport 25(1):23–27PubMed
81.
82.
Ugur C, Gürkan C (2014) Serum vitamin D and folate levels in children with autism spectrum disorders. Res Autism Spectr Disord 8:1641–1647CrossRef
83.
Hashemzadeh M, Moharreri F, Soltanifar A (2015) Comparative study of vitamin D levels in children with autism spectrum disorder and normal children: a case–control study. J Fundam Ment Health 17:197–201
84.
Saad K et al (2016) Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children. Nutr Neurosci 19(8):346–351
85.
86.
87.
Tolppanen AM et al (2012) The association of serum 25-hydroxyvitamin D3 and D2 with depressive symptoms in childhood–a prospective cohort study. J Child Psychol Psychiatry 53(7):757–766PubMedCrossRef
88.
89.
Sullivan S et al (2013) Prenatal vitamin D status and risk of psychotic experiences at age 18 years-a longitudinal birth cohort. Schizophr Res 148(1–3):87–92PubMedCrossRef
90.
91.
Morales E et al (2015) Vitamin D in pregnancy and attention deficit hyperactivity disorder-like symptoms in childhood. Epidemiology 26(4):458–465PubMedCrossRef
92.
Whitehouse AJ et al (2013) Maternal vitamin D levels and the autism phenotype among offspring. J Autism Dev Disord 43(7):1495–1504PubMedCrossRef
93.
Fernell E et al (2010) Serum levels of 25-hydroxyvitamin D in mothers of Swedish and of Somali origin who have children with and without autism. Acta Paediatr 99(5):743–747PubMedCrossRef
94.
Azzam HME et al (2015) Autism and vitamin D: an intervention study. Middle East Curr Psychiatry 22:9–14CrossRef
95.
Jia F et al (2015) Core symptoms of autism improved after vitamin D supplementation. Pediatrics 135(1):e196–e198PubMedCrossRef
96.
Stubbs G, Henley K, Green J (2016) Autism: will vitamin D supplementation during pregnancy and early childhood reduce the recurrence rate of autism in newborn siblings? Med Hypotheses 88:74–78PubMedCrossRef
97.
Ucuz II et al (2015) The relationship between vitamin D, autistic spectrum disorders, and cognitive development: do glial cell line-derived neurotrophic factor and nerve growth factor play a role in this relationship? Int J Dev Disabil 61:222–230CrossRef
98.
Hogberg G et al (2012) Depressed adolescents in a case-series were low in vitamin D and depression was ameliorated by vitamin D supplementation. Acta Paediatr 101(7):779–783PubMedCrossRef
99.
Gloth FM 3rd, Alam W, Hollis B (1999) Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 3(1):5–7PubMed
100.
Tartagni M et al (2016) Vitamin D supplementation for premenstrual syndrome-related mood disorders in adolescents with severe hypovitaminosis D. J Pediatr Adolesc Gynecol 29(4):357–361PubMedCrossRef
101.
Gowda U et al (2015) Vitamin D supplementation to reduce depression in adults: meta-analysis of randomized controlled trials. Nutrition 31(3):421–429PubMedCrossRef
102.
Li G et al (2014) Efficacy of vitamin D supplementation in depression in adults: a systematic review. J Clin Endocrinol Metab 99(3):757–767PubMedCrossRef
103.
Shaffer JA et al (2014) Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosom Med 76(3):190–196PubMedPubMedCentralCrossRef
104.
Spedding S (2014) Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients 6(4):1501–1518PubMedPubMedCentralCrossRef
105.
106.
Vaziri F et al (2016) A randomized controlled trial of vitamin D supplementation on perinatal depression: in Iranian pregnant mothers. BMC Pregnancy Childbirth 16:239PubMedPubMedCentralCrossRef
107.
Wang Y et al (2013) Effects of vitamin C and vitamin D administration on mood and distress in acutely hospitalized patients. Am J Clin Nutr 98(3):705–711PubMedCrossRef
108.
Frandsen TB et al (2014) Vitamin D supplementation for treatment of seasonal affective symptoms in healthcare professionals: a double-blind randomised placebo-controlled trial. BMC Res Notes 7:528PubMedPubMedCentralCrossRef
109.
Harris S, Dawson-Hughes B (1993) Seasonal mood changes in 250 normal women. Psychiatry Res 49(1):77–87PubMedCrossRef
110.
Lansdowne AT, Provost SC (1998) Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology 135(4):319–323PubMedCrossRef
111.
Dumville JC et al (2006) Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women. J Nutr Health Aging 10(2):151–153PubMed
112.
Khajehei M et al (2009) Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome. Int J Gynaecol Obstet 105(2):158–161PubMedCrossRef
113.
Belcaro G et al (2010) MF Afragil(R) in the treatment of 34 menopause symptoms: a pilot study. Panminerva Med 52(2 Suppl 1):49–54PubMed
114.
Jorde R et al (2008) Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 264(6):599–609PubMedCrossRef
115.
Arvold DS et al (2009) Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial. Endocr Pract 15(3):203–212PubMedCrossRef
116.
Dean AJ et al (2011) Effects of vitamin D supplementation on cognitive and emotional functioning in young adults—a randomised controlled trial. PLoS One 6(11):e25966PubMedPubMedCentralCrossRef
117.
Sanders KM et al (2011) Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br J Psychiatry 198(5):357–364PubMedCrossRef
118.
Bertone-Johnson ER et al (2012) Vitamin D supplementation and depression in the women’s health initiative calcium and vitamin D trial. Am J Epidemiol 176(1):1–13PubMedPubMedCentralCrossRef
119.
Yalamanchili V, Gallagher JC (2012) Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms. Menopause 19(6):697–703PubMedPubMedCentralCrossRef
120.
Kjaergaard M et al (2012) Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case–control study and randomised clinical trial. Br J Psychiatry 201(5):360–368PubMedCrossRef
121.
Khoraminya N et al (2013) Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Aust N Z J Psychiatry 47(3):271–275PubMedCrossRef
122.
Mozaffari-Khosravi H et al (2013) The effect of 2 different single injections of high dose of vitamin D on improving the depression in depressed patients with vitamin D deficiency: a randomized clinical trial. J Clin Psychopharmacol 33(3):378–385PubMedCrossRef
123.
Autier P et al (2014) Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2(1):76–89PubMedCrossRef
124.
McCann JC, Ames BN (2008) Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 22(4):982–1001PubMedCrossRef
125.
Katrinaki M et al (2016) Vitamin D levels in a large Mediterranean cohort: reconsidering normal cut-off values. Hormones (Athens) 15(2):205–223CrossRef
126.
Luxwolda MF et al (2012) Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr 108(9):1557–1561PubMedCrossRef
127.
Vogiatzi MG et al (2014) Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature. J Clin Endocrinol Metab 99(4):1132–1141PubMedCrossRef
128.
Vieth R (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69(5):842–856PubMed
129.
Zittermann A (2014) Vitamin D and cardiovascular disease. Anticancer Res 34(9):4641–4648PubMed
130.
131.
Guessous I (2015) Role of vitamin D deficiency in extraskeletal complications: predictor of health outcome or marker of health status? Biomed Res Int 2015:563403PubMedPubMedCentralCrossRef
132.
Bolland MJ et al (2014) The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2(4):307–320PubMedCrossRef
133.
Bolland MJ et al (2014) Vitamin D supplementation and falls: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2(7):573–580PubMedCrossRef
134.
Autier P (2016) Vitamin D status as a synthetic biomarker of health status. Endocrine 51(2):201–202PubMedCrossRef
135.
Gillie O (2016) Vitamin D, causation, conflict of interest and other issues—CORRIGENDUM. Public Health Nutr 19(3):417PubMedCrossRef
136.
Gillie O (2016) Controlled trials of vitamin D, causality and type 2 statistical error. Public Health Nutr 19(3):409–414PubMedCrossRef
137.
Cannell JJ, Grant WB, Holick MF (2014) Vitamin D and inflammation. Dermatoendocrinology 6(1):e983401CrossRef
138.
139.
Pilz S et al (2011) Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 58(3):374–382PubMedCrossRef
140.
141.
Tanaka H et al (2009) The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. Bone 45(5):949–955PubMedCrossRef
142.
Oh C et al (2017) The most effective factors to offset sarcopenia and obesity in the older Korean: physical activity, vitamin D, and protein intake. Nutrition 33:169–173
143.
144.
del Giudice Miraglia et al (2015) Bioavailable vitamin D in obese children: the role of insulin resistance. J Clin Endocrinol Metab 100(10):3949–3955CrossRef
145.
Karlsson T et al (2014) Increased vitamin D-binding protein and decreased free 25(OH)D in obese women of reproductive age. Eur J Nutr 53(1):259–267PubMedCrossRef
146.
Holmlund-Suila E et al (2016) Obese young adults exhibit lower total and lower free serum 25-hydroxycholecalciferol in a randomized vitamin D intervention. Clin Endocrinol (Oxf) 85(3):378–385CrossRef
147.
Walsh JS et al (2016) Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health. Am J Clin Nutr 103(6):1465–1471PubMedCrossRef
148.
Thompson RA, Nelson CA (2001) Developmental science and the media. Early brain development. Am Psychol 56(1):5–15PubMedCrossRef
149.
Akman AO et al (2011) Frequency of vitamin D insufficiency in healthy children between 1 and 16 years of age in Turkey. Pediatr Int 53(6):968–973PubMedCrossRef
150.
Andersen R et al (2005) Teenage girls and elderly women living in northern Europe have low winter vitamin D status. Eur J Clin Nutr 59(4):533–541PubMedCrossRef
151.
152.
Guillemant J et al (2001) Wintertime vitamin D deficiency in male adolescents: effect on parathyroid function and response to vitamin D3 supplements. Osteoporos Int 12(10):875–879PubMedCrossRef
153.
154.
Rodriguez-Rodriguez E et al (2011) Vitamin D status in a group of Spanish schoolchildren. Minerva Pediatr 63(1):11–18PubMed
155.
Stellinga-Boelen AA et al (2007) Vitamin D levels in children of asylum seekers in The Netherlands in relation to season and dietary intake. Eur J Pediatr 166(3):201–206PubMedCrossRef
156.
Vieth R et al (2004) Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J 3:8PubMedPubMedCentralCrossRef
157.
Zhang M et al (2011) Vitamin C provision improves mood in acutely hospitalized patients. Nutrition 27(5):530–533PubMedCrossRef
Metadata
Title
Vitamin D and mental health in children and adolescents
Authors
Manuel Föcker
Jochen Antel
Stefanie Ring
Denise Hahn
Özlem Kanal
Dana Öztürk
Johannes Hebebrand
Lars Libuda
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
European Child & Adolescent Psychiatry / Issue 9/2017
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-017-0949-3

Other articles of this Issue 9/2017

European Child & Adolescent Psychiatry 9/2017 Go to the issue

Review

Elimination diets’ efficacy and mechanisms in attention deficit hyperactivity disorder and autism spectrum disorder

Original Contribution

Associations between social vulnerabilities and psychosocial problems in European children. Results from the IDEFICS study

Original Contribution

Genetic and environmental correlations between subjective wellbeing and experience of life events in adolescence

Review

Food matters: how the microbiome and gut–brain interaction might impact the development and course of anorexia nervosa

Original Contribution

Predicting academic impairment and internalizing psychopathology using a multidimensional framework of Sluggish Cognitive Tempo with parent- and adolescent reports

Review

Gut microbiota and attention deficit hyperactivity disorder: new perspectives for a challenging condition